Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
about
Immune evasion by murine melanoma mediated through CC chemokine receptor-10Defining immune engagement thresholds for in vivo control of virus-driven lymphoproliferationCrystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognitionMHC Class I Bound to an Immunodominant Theileria parva Epitope Demonstrates Unconventional Presentation to T Cell ReceptorsDisparate Epitopes Mediating Protective Heterologous Immunity to Unrelated Viruses Share Peptide-MHC Structural Features Recognized by Cross-Reactive T CellsSerine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsDifferential expression of tapasin and immunoproteasome subunits in adenovirus type 5- versus type 12-transformed cellsRecycling MHC class I molecules and endosomal peptide loadingAn RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse modelSialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responsesBrain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residueEndogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease.Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog.Regulation of CD1 antigen-presenting complex stability.The endoplasmic reticulum lumenal domain of the adenovirus type 2 E3-19K protein binds to peptide-filled and peptide-deficient HLA-A*1101 molecules.Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: optimization by different ways of sequence rearrangements (shuffling).A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form.The melting pot of the MHC II peptidomeThe first step of peptide selection in antigen presentation by MHC class I molecules.Novel designs of single-chain MHC I/peptide complex for the magnetosome display system.Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytesPromiscuous binding of extracellular peptides to cell surface class I MHC proteinHierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccinesLong-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules.The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure.Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface.Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide.Peptide-induced stabilization and intracellular localization of empty HLA class I complexes.Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene.Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture.Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum.Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide.The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E betaIncrease in positive selection of CD8+ T cells in TAP1-mutant mice by human beta 2-microglobulin transgeneSelective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide
P2860
Q24672380-FC4B5C61-67D1-42CB-A643-1EA37B26BF60Q27324746-CB272E9F-A139-4A75-B626-6AB6F3C0E4ABQ27642083-0FFCC152-53DD-4722-998A-1DD148F1052FQ27665375-B9D2E453-F518-462F-9D3D-65C08C5ED9F4Q27680365-AF63BB1A-6BA5-4673-BB05-66F4F5FAAABAQ28202640-FA25CCD6-D300-40B8-8CC7-11E9CEFE2F76Q28570543-74F025CA-C196-46EF-846E-F9A3CBDE281AQ28609669-A98FCDCE-0388-43A1-9AA1-D55F09AD6A2EQ29365281-B2A7BE6C-8A77-4481-B7B8-BDC4368277C7Q30367426-07EF2E10-C204-486E-823B-B04DD9663790Q30452573-796AA33C-9051-4611-952C-7712666CD4FBQ30469614-1EAA751D-E71D-4056-A827-02CFE8A5D1C6Q30852493-F542C069-A5E7-425C-BD89-D9EFE5E0D62CQ33782034-02E46B8A-B87E-476C-8D40-087D68F74D85Q33782467-A20B8DCF-CF09-47F7-8872-A7694D71503DQ34092778-CEBB7B82-E25D-454A-B2B4-B4E4D797ECE9Q34571825-FEABBDC0-0A6C-48A9-972E-BF22C55BF859Q34648146-70BA93C0-E173-4950-B3B0-E62F6D667F24Q34676583-C84EFE41-846D-4A13-B0CD-FE8A27543015Q35062805-7CC00287-41B3-4949-ACD3-88CBFA42C9E2Q35540721-83BF519E-E0CB-462F-8F9C-5AA513B2A033Q35837639-4B105C68-CEBC-4AB8-A52B-6D4DE375926BQ35849608-3A0CB27A-B731-4721-8465-2C3016B59E73Q35895384-1CB45E13-5F98-4091-9162-706B0AFFC5D5Q35979288-70B558A6-805A-443C-B1F8-B4E14662322CQ36229848-7ABECF7B-3F77-4E77-85D6-5879C6D0307BQ36230616-4736A572-1EC9-4F9F-97D1-5F64673EC0D8Q36230853-218D1696-5D76-4D8C-BE20-8C95B5927736Q36231365-699C5809-1EB2-48AD-BC18-965FD3C1DC83Q36231485-C41F46D1-8762-4454-A55F-B1516A39E99BQ36232028-51825F33-F9A5-4FC1-88B9-7AD1EF1F87BDQ36361210-93468412-A631-41C1-86C7-BD047D13AD35Q36361722-9634652A-E293-4DAE-8FC6-E756FA6684EAQ36361774-200C0AFE-01AD-4810-9A1A-108086DE5695Q36363273-CEB1B7EF-F22D-43F3-BFA7-BAD626659237Q36363521-E4F4B573-E9D5-4F77-92F8-CC87CAC8108CQ36364103-E3784008-B187-4686-B0C5-4AAD24981186Q36364401-2350D238-90DE-4233-A150-F91EA743A5E3Q36364433-0252E62B-19B0-4D68-980B-7B32CB100E92Q36366862-229B21F2-AEF1-4238-9916-86B151F0A498
P2860
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
@en
type
label
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
@en
prefLabel
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
@en
P2093
P1433
P1476
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro
@en
P2093
C J Melief
H L Ploegh
J J Neefjes
T N Schumacher
P304
P356
10.1016/0092-8674(90)90020-F
P407
P50
P577
1990-08-01T00:00:00Z